Investments
4Portfolio Exits
1
Want to inform investors similar to Hongkou Capital about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Hongkou Capital News
Feb 15, 2022
Day Zero Diagnostics, a Boston, MA-based infectious disease diagnostics company, raised USD 21M in funding. The round was led by Sands Capital, with participation from BD, Panacea Venture, Hongkou Capital, Triventures and Golden Seeds.
Hongkou Capital Investments
4 Investments
Hongkou Capital has made 4 investments. Their latest investment was in Amionx as part of their Series B on October 10, 2021.
Hongkou Capital Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
10/5/2021 | Series B | Amionx | $6.03M | Yes | 5 | |
7/19/2021 | Series C | |||||
7/14/2021 | Series B | |||||
4/27/2021 | Series D |
Date | 10/5/2021 | 7/19/2021 | 7/14/2021 | 4/27/2021 |
|---|---|---|---|---|
Round | Series B | Series C | Series B | Series D |
Company | Amionx | |||
Amount | $6.03M | |||
New? | Yes | |||
Co-Investors | ||||
Sources | 5 |
Hongkou Capital Portfolio Exits
1 Portfolio Exit
Hongkou Capital has 1 portfolio exit. Their latest portfolio exit was Exscientia on October 01, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
10/1/2021 | IPO | Public | 3 |
Date | 10/1/2021 |
|---|---|
Exit | IPO |
Companies | |
Valuation | |
Acquirer | Public |
Sources | 3 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.